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Preface 
 
Medical record abstraction is the process in which a human manually searches through a medical record 
to identify data required for a secondary use. Abstraction involves some direct matching of information 
found in the record to the data required, but also includes operations on the data such as categorizing, 
coding, transforming, interpreting, summarizing, and calculating. The abstraction process results in a 
summary of information about a patient for a specific secondary data use. Medical Record Abstraction 
remains a primary mode of data collection in clinical research, quality improvement, performance 
measurement, disease surveillance, and other secondary data uses.  
 
While hundreds of articles mention factors that may impact the accuracy of abstracted data, the 
information in the literature until now has not been synthesized, and the majority of the work has been 
done in the absence of a theoretical framework. 
 
Information generation, collection, and representation are central to informatics. Generation, collection, 
and representation impact data and information quality; in turn, data and information quality impact use.  
Medical Record Abstraction is about the interaction of humans with the processes, tools, representations, 
and environment in which the abstraction occurs. In medical record abstraction, a human being is an 
agent in the collection and transformation of data. That human-data-representation interaction is an 
informatics problem that, until now, has not yet been addressed from an informatics perspective. 
 
The work presented here was motivated by the lack of consensus and lack of evidence supporting 
methods used in the collection and management of clinical research data and their impact on the quality 
of the data.  This work began with a quantitative literature review and pooled analysis of data error rates 
reported in the clinical trial and registry literature.  This first paper included in this compilation associated 
medical record abstraction with the highest error rates of the data collection and processing methods 
common in clinical research. Thus, data quality in medical record abstraction became the focus of further 
investigation. 
 
The second paper in the compilation, a formal concept analysis of data quality, was necessary for further 
investigation of data quality in medical record abstraction. The concept analysis clarified the 
multidimensionality of data quality, and focused my work on the dimension of data accuracy, i.e., 
correctness of the data values.  
 
My study of data accuracy in medical record abstraction was initiated with a review and formal synthesis 
of the medical record abstraction literature. Working with the literature helped identify appropriate 
theoretical frameworks and led the way to a classification system for factors impacting the accuracy of 
medical record abstraction. The factors impacting data accuracy in medical record abstraction reported in 
the literature were assed (content validity) through a two cohort, four round Delphi process. The third 
paper in this compilation presents the results of this work. 
 
The fourth and final paper in this compilation investigates one factor, cognitive load, consistently 
indicated in the literature as impacting data accuracy in medical record abstraction.  Representational 
Analysis methodology was applied to asses the possibility that abstractor cognitive load during 
abstraction reaches published limits of human cognition.  This work demonstrated that cognitive load 
during abstraction from characteristics of the data elements alone, not only reaches, but in 9% of the data 
elements, exceeds human cognitive limits.  
 
This work lays the groundwork for additional research and furthers both the science of informatics and 
the clinical and translational research to which it is applied.  
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Abstract 
We present a literature review and secondary analysis of data accuracy in clinical research and 
related secondary data uses. A total of 93 papers meeting our inclusion criteria were categorized 
according to the data processing methods. Quantitative data accuracy information was abstracted 
from the articles and pooled. Our analysis demonstrates that the accuracy associated with data 
processing methods varies widely, with error rates ranging from 2 errors per 10,000 files to 5019 
errors per 10,000 fields. Medical record abstraction was associated with the highest error rates 
(70–5019 errors per 10,000 fields). Data entered and processed at healthcare facilities had 
comparable error rates to data processed at central data processing centers. Error rates for data 
processed with single entry in the presence of on-screen checks were comparable to double 
entered data. While data processing and cleaning methods may explain a significant amount of 
the variability in data accuracy, additional factors not resolvable here likely exist. 
 
Abstract Word Count: 150 words   
 
Key Words: Data management; Data quality; Clinical research; Registries; Electronic data 
processing; Chart review; Medical record abstraction; Data collection 
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Introduction 
Computers have been used in clinical research since the early 1960s, although initial efforts to 
integrate them into such efforts were experimental and sporadic [1,2]. The early application of 
computers to health-related research spawned a plethora of methods for collecting and preparing 
data for analysis [3,4]. These functions, which are central to the field of clinical research 
informatics, are evaluated by metrics of cost, time, and quality [5]. While cost and time affect the 
feasibility of research, and timeliness is certainly critical to the conduct and oversight of 
research, the scientific validity of research conclusions depends on data quality in general and 
data accuracy in particular [6]. 
 Reports on data accuracy assessments begin in the late 1970s [7] and continued throughout 
the 1980s [8-12]. Although data accuracy is likely attributable to how data are collected, entered, 
and cleaned, or otherwise processed, no systematic reviews of the clinical research data quality 
literature have been conducted to date. In 2002, Arts published a review of data quality in 
medical research registries [13]. Although a significant contribution, Arts’ work was limited in 
scope to registries and did not include other secondary uses, such as clinical trials.  
 Several texts describe approaches to general data quality management independent of the 
domain area of the application [14-17]. These works focus on general methods for assessing and 
documenting data quality, as well as methods for storing data in ways that maintain or improve 
their quality. As such, the works abstract above data collection and processing methods 
applicable to specific industries and types of data. They provide little to no guidance to 
investigators and research teams planning a clinical research endeavor or attempting to 
operationalize data collection and management.   
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Background 
Many authors in the clinical research arena lament the paucity of published information 
regarding clinical trials data quality [5,6,8,12,18-26]. While most authors point out that 
conclusions drawn from studies depend on data quality (and the underlying data collection and 
management methods), others label the associated tasks mundane [27,28]. This perception has 
perhaps resulted in the minimal degree of investigation and associated low number of 
publications on the topic of data collection and management, compared with other areas of 
clinical research and informatics methodology. An initial step in seeking such information and 
providing guidance to investigators and research teams is a thorough review and synthesis of the 
relevant published literature. 
 With the current rapid influx of new technology into healthcare and clinical research, the 
quality of data quality achievable using available methods becomes even more important; e.g., 
learning from the past, and providing benchmarks for new technology evaluation [29]. Many 
unresolved issues exist with respect to data quality in clinical research, including a thorough 
understanding of the accuracy and variability of current data processing methods. Thus, a 
synthesis of information about clinical research data quality from the literature is a critical 
contribution to both clinical research informatics and clinical and translational research.   
 Historically, data processing methods used across clinical research show significant 
variability [3,4,30]. Briefly, according to Medical Subject Headings (MeSH) terminology, 
registries are the ‘‘systems and processes involved in the establishment, support, management, 
and operation of registers (sic), e.g., disease registers.” In a 2008 paper, Drolet distinguishes 
registries from simple databases or other non-registry data repositories and presents six criteria 
for medical data registries [31]. Not evident in his definition, however, are the wide variety of 
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data processing methods used for medical data registries. These include: 1) chart review and 
abstraction versus direct electronic acquisition from electronic medical records; 2) use of vended 
data collection systems by local healthcare facilities (e.g., data entry and cleaning in local 
systems versus Web-based data entry and cleaning in a centrally hosted system); 3) use of paper 
data collection forms and central processing; and 4) single versus double data entry. Data 
cleaning methods also vary greatly, from use of “reports of things to consider for the next data 
submission,” to on-screen checks during data entry, to post-entry batch data processing. 
 Except for the ongoing transition from paper-based data collection to Web-based collection, 
methods used to gather and process data for industry-sponsored clinical trials performed in 
support of marketing authorization have remained fairly uniform over the 30-year span of the 
literature base. Generally, in this highly regulated variety of clinical research, data are abstracted 
from patient charts, then transcribed onto either paper forms or electronic data capture (EDC) 
systems. Where paper forms are used, data are forwarded to a central data center, double-entered, 
and subjected to data cleaning checks. Discrepancy reports are sent to the clinical investigational 
sites, and resolutions to any queries are received in return; based on these responses, the database 
is then updated. In contrast, data collected on modern EDC trials are generally single-entered at 
clinical investigational sites in centrally hosted Web-based systems that employ on-screen data 
cleaning checks.  
 Data collection and processing for clinical research funded by non-industry means (such as 
trials funded by governmental and foundational resources), varies widely. As with registries and 
market-oriented clinical research, the process typically starts with chart review, also called 
medical record abstraction (or simply “abstraction”). Small early-phase or low-budget projects, 
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however, often employ commercially-available spreadsheets for data collection and 
management, and manual data review for data cleaning.  
 Unfortunately, while use of spreadsheets in research is ubiquitous, there are few reports on 
how this affects data quality [32-36]. Both small and mid-size projects often use Microsoft 
Access (Redmond, WA) or similar pseudo-relational data systems that provide utilities for 
creating data entry screens, a scripting language for error checks, and a data storage mechanism. 
Data entry in such systems tends to be single entry, with a combination of on-screen and post-
entry data cleaning.  
 Similarly, some investigators choose to enter data directly into statistical analysis packages 
such as SPSS (Chicago, IL) or SAS (Cary, NC). Larger government- and foundation-funded 
projects tend to use custom data collection systems developed specifically for a given project; 
many of these use relational database management systems. There has been a recent trend in 
government-funded projects toward specialized, vended clinical data management systems 
employed in regulated clinical trials. These systems support multiple workflows, and different 
data processing methodologies. 
 Thus, historically, data collection and processing methods have varied greatly across types of 
clinical research, and there has been little comparative evaluation of different methods and 
technologies. Key events, however, signal an increasing convergence in methods. These include: 
1) industry contract research organizations serving as data centers for government-funded 
research; 2) use of central data centers for government-funded work; 3) a recent increase in 
academic membership in the historically industry-based Society for Clinical Data Management; 
4) National Institutes of Health (NIH) contract and grant solicitations that require compliance 
with industry regulations; and 5) government adoption of vended clinical data management 
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systems [30]. Convergence of such great variability necessitates comparative evaluation of 
methods and technologies of data collection and management with respect to cost and data 
quality [29]. 
 Significant variability also exists in quantitative methods for assessing data accuracy across 
clinical research and other secondary data uses [13,37,38]. Data accuracy has often been 
measured in terms of database error rates (registries also often assess percent completeness, and, 
thus evaluate data quality in terms of data accuracy and completeness). The error rate is defined 
in the Good Clinical Data Management Practices document (GCDMP) as the number of errors 
divided by the number of data values inspected [37], a method used in other industries as well 
[39].   
 
inspectedvaluesofnumber
errorsofnumber
rateError   
 
As described in the GCDMP and elsewhere [40], there are significant differences in the way 
errors and values are inspected and counted. Based on these counting differences, the error rates 
obtained can differ by a factor of two or more [37,38]. In addition, differences in how error rates 
are reported (e.g., as raw counts, errors per record, or errors per 10,000 fields), necessitate 
scaling and normalization of the values reported in the literature before meaningful comparisons 
can be made.   
 Assessment and quantification of data accuracy is crucial to scientific inquiry. Errors 
increase variance, which in turn diminishes statistical power. Three papers report simulations of 
power loss or related constructs for different error rates [23,41,42]. Rostami et al. provide an 
analytical solution for the impact of database errors on reliability and show the resulting increase 
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in sample size necessary to compensate for the loss of statistical power for given error rates in 
the dependent analysis variable [40].    
 The effect of errors on data quality is dependent on the variable in which the error occurs; 
i.e., in major independent or dependent variables or covariates [43]. The impact is also dependent 
on the robustness of the particular analytical method used. Thus, there is no regulatory or one-
size-fits-all standard error rate for clinical research. A 1999 Institute of Medicine report 
emphasizes this by defining quality data in clinical research as “data that support the same 
conclusions as error free data [6].” 
 One balancing factor, the cost and time associated with cleaning data, can account for 
upwards of 10%–20% of the cost of a clinical trial [44]. Thus, cleaning data to appropriate 
quality levels and not beyond is clearly the target. To support this, a thorough characterization of 
data processing methods with respect to data accuracy is clearly needed to identify the most cost-
effective balance. To that end, we undertook a review and secondary analysis of the relevant 
literature to characterize data processing methods with respect to quality.  
 
Purpose 
We sought to synthesize the literature on data quality in clinical research and registries. Four 
main questions comprise the focus of this research: 
1. How much, and what kind of, quantitative data quality information is reported in the 
literature?  
2. What data collection and processing methods are described? Secondarily, is the 
information applicable to newer data processing methods (such as Web-based EDC) in 
clinical research?  
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3. Do error rates differ by data processing method? If so, how and by how much?  
4. Are some data processing methods inherently more variable than others? If so, to what 
extent? 
 
Methods 
Criteria for inclusion of manuscripts 
The criteria for inclusion in this analysis were as follows: 1) articles must be manuscripts 
published in peer review j urnals indexed for retrieval, be referenced by such, or be publicly 
available; 2) have a focus on secondary data use (e.g., clinical research, quality improvement, 
surveillance, research registries); 3) the database error rate must be presented or resolvable (e.g., 
via number of errors identified and number of fields inspected, or must contain sufficient 
information to calculate); 4) must describe how the data were processed (e.g., optical scanning, 
single or double entry); 5) must be written in the English language; and 6) must be a primary 
source for the error rate. The following parameters were optional: data cleaning method, location 
of data processing (central data center vs. local healthcare facility), gold standard used, and 
scope of method of comparison. 
 
Information retrieval 
A PubMed search on the Medical Subject Heading (MeSH) terms “data quality” AND (registry 
or “clinical trial”) produced 350 citations through 2008. Review of the 350 abstracts produced 
54 articles deemed likely to contain quantitative information about data quality; the full text of 
these 54 articles was reviewed. PubMed related links and secondary and tertiary references from 
10
Journal of the Society for Clinical Trials
Clinical Trials
For Peer Review
the 54 articles identified an additional 70 articles of interest. After full-text review of the 124 
articles, 93 articles met our criteria and were used in this analysis. 
 
The literature 
The literature in this area spans publication dates from 1978–2008. The clinical research data 
quality literature base is fragmented across 60 distinct journals, including medical specialty 
journals, statistics journals, clinical research journals, and informatics journals. Journals with 
more than one article meeting our inclusion criteria are listed in Table 1.   
 Although articles could be categorized by the clinical area of interest, categorization by type 
of secondary use and data processing method is more germane to our investigation. The literature 
is categorized into major groupings according to type of secondary use, data processing method, 
and data accuracy assessment method in Table 2. The categories in Table 2 represent 
combinations of common factors and are not mutually exclusive; thus, some articles appear in 
more than one category. Importantly, all articles used in our analysis are included in Table 2. 
 
Data collection and analysis 
Three types of data were collected from each article: 1) information about how data were processed 
[Table 3]; 2) information about how data quality was measured [Table 4]; and 3) number of errors 
and number of fields inspected. Prior to quantitative data analysis, the factors shown in Tables 3 
and 4 were developed in a qualitative, iterative manner during the review of the articles. Attributes 
of the data processing and quality measurement as reported were noted as each article was read. 
Natural groupings were organized into the categories displayed in Tables 3 and 4. These categories 
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were later explored in the analysis to ascertain which (if any) of the factors might affect data 
quality. 
 In the literature, data quality is presented in several different ways, including overall 
agreement, kappa, (), number of erroneous fields per number of records reviewed, number of 
erroneous fields per number of fields (values) reviewed, number of errors per number of 
keystrokes, and specificity and sensitivity. Traditionally, where a gold standard is used for 
comparison, overall agreement is reported, whereas if the researcher believes there is no gold 
standard (often the case of two independent raters),  is reported. We abstracted the number of 
errors reported and the total number of data fields (values) inspected. In one case, an author was 
contacted to confirm the number of fields inspected. Four articles [9,41,88,102] presented only 
normalized error rates as errors per 10,000 fields; for these, the denominator was assumed for the 
total number of fields inspected. The number of errors and number of fields inspected were used 
to calculate normalized error rates (number of errors per 10,000 fields) based on the 
recommendations in GCDMP [37].  
 Each article described a data quality assessment of one or more databases. Where error rates 
for more than one database or assessment were provided in an article, each is included in this 
analysis. Likewise, in some articles, error rates were reported for more than one process step; for 
example, medical record to Case Report Form (CRF), CRF to first entry, first entry to second 
entry, or CRF to clean file. Where error rates for multiple data processing steps were provided, 
we include them here; thus, the number of data points is higher than the number of reviewed 
papers. A total of 22 articles reported results for more than one processing step, process or 
database [9,11,13,22,32,54,55,63,64,66,74,79-81,83-85,87,96,102,114,121], providing a total of 
125 data points. 
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 For consistency, one rater was used to abstract the error rate information from the articles 
(MN). A sample of the manuscripts included in the analysis, comprising 10% of the total, was re-
evaluated following the initial abstraction to assess reliability. For the sample, the time between 
the initial and intra-rater reliability review was at least 1 year. Intra-rater reliability, calculated as 
percent difference, was used to gauge reliability of the data. The intra-rater reliability for number 
of errors, number of fields, and error rate were 85%, 97%, and 86% respectively. In addition, a 
second rater (CJ) reviewed the same intra-rater reliability sample, with comparable results. In 
light of the underlying variability in the data, the variability in error rate calculation methods 
currently in use, and the aims of this study, these were considered reasonable. In addition, they 
are comparable to those in a similar review paper of errors in electronic medical records [123]. 
 Two reviews of data accuracy in electronic medical records report variability in the methods 
used to measure accuracy [123,124]. Both reviews concluded that the methodological variability 
was sufficiently significant to preclude pooled analysis. However, Hogan and Wagner stated that 
assessment methods in the field of clinical research were more uniform, an assessment similar to 
our own. We therefore pursued a pooled analysis and normalized error rates from the literature. 
From this analysis, we present descriptive statistics and confid nce intervals.   
 
Results 
The data obtained from our literature review are displayed in Figure 1, which shows all 125 data 
points normalized as number of errors per 10,000 fields and demonstrates the dispersion over 
time of the health-related research literature with respect to data accuracy. Database error rates 
ranged from 2–5019 errors per 10,000 fields. This three orders-of-magnitude range necessitated a 
logarithmic display. There appears to be no pattern in the year-to-year reporting. It is reasonable 
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to assume that if adoption and implementation of new technology tended to increase data quality, 
such a trend would be evident in the graph. One possible explanation for the lack of such a trend 
is that adoption and implementation of new technology throughout the years has not increased 
the data accuracy. Another possibility is that data accuracy is not considered in new technology 
evaluation and implementation. 
 In order to explore possible differences in data quality for different data processing methods, 
data were categorized according to the method used to process the data, shown in Figure 2.  
Source-to-database and source-to-CRF were combined into a single category labeled abstraction 
based on: 1) some of the articles reported error rates for abstraction directly to an electronic data 
collection form; i.e., no separate data entry step, and 2) the central tendency and dispersion of the 
two processes being similar. Data have been horizontally jittered to more fully display the data 
set.  The median (horizontal bar) is overlaid on each group. The source-to-database error rates 
ranged from 82–5019 errors per 10,000 fields; the source-to-CRF error rates ranged from 70– 
3360 errors per 10,000 fields. Optical scanning error rates ranged from 2–1106 errors per 10,000 
fields. Single-entry error rates ranged from 4–650 errors per 10,000 fields, while double-entry 
error rates ranged from 4–33 errors per 10,000 fields. Additional descriptive statistics are 
provided in Table 5. 
 Several salient features are apparent in Figure 2. First, ordered by the median, medical record 
abstraction is associated with the highest error rate, followed by optical methods and single 
entry, while double data entry, the least complex and most controlled, is associated with the 
lowest error rate. Importantly, abstraction, optical methods, and single entry all are associated 
with significant variability. Notably, the error rates reported for both medical record abstraction 
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and optical methods span three orders of magnitude. For optical methods, there were too few 
data points to support a subgroup analysis.  
 For single entry, there were both a sufficient number of data points and detail regarding 
different methods to perform a subgroup analysis (Figure 3), in which we examined the effects of 
aspects of data processing reported in the literature, including the presence of on-screen checks, 
use of batch data cleaning, and the location of data processing. These variations are examined 
here because they represent key data processing options in current Web-based EDC systems, but 
as they constitute small subgroups, any findings from their analysis should be considered only as 
indicators of potential trends. For example, labels such as “batch data cleaning” or “on-screen 
checks” were only applied where the original manuscript specifically so noted; therefore, the 
other data points may or may not have employed batch data cleaning or on-screen checks. 
Location of data processing (e.g., at local facilities versus central data centers), was discernable 
from all articles.  
 Analysis of the subgroup data revealed the following patterns. Location of data processing 
appeared to have little effect on data accuracy. When both distributed and centrally entered data 
are considered together, on-screen checks (OSC) were associated with a decrease in average 
error rates, from 158 errors per 10,000 fields to 23; in addition, variability was correspondingly 
decreased from 211 errors per 10,000 fields to 15 (the categories labeled “All” in Figure 3). The 
trend is the same for data entered at clinical sites (“distributed OSC” in Figure 3), where on-
screen checks were associated with a decreased average error rate of 28 errors per 10,000 fields, 
comparable to the average quality obtained from double entry. Importantly, the data presented in 
Figure 3 represent only data processing accuracy—they do not include errors that may result 
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from upstream processes (such as errors in the medical record itself or errors arising from 
abstraction process). Descriptive statistics for Figure 3 are shown in Table 6a. 
 The predominant method of clinical research data collection in the near future will likely be 
Web-based EDC. Due to the importance of this particular model, articles reporting data accuracy 
from similar data processing configurations (e.g., central versus distributed data processing in the 
presence of OSC), were examined (Figure 4). Similar to the single-entry subgroup results, this 
analysis showed little difference in error rates for centrally versus locally processed data. Thus, 
the EDC model is likely capable of providing accuracy comparable to that of centrally processed 
data. As in Figure 3, the data presented in Figure 4 represent only data processing accuracy. 
Descriptive statistics are provided in Table 6b. 
 Finally, we examined the effect of batch data cleaning on error rates. This analysis was 
performed on the entire data set. Only 19 of the studies we examined reported on whether batch 
data cleaning techniques were employed. We conservatively grouped articles that explicitly 
stated that no batch data cleaning was used with articles that made no mention of batch data 
cleaning. This analysis (Figure 5) showed that batch data cleaning was associated with lower 
error rates and decreased variability (descriptive statistics are r ported in Table 7). Databases 
employing batch data cleaning were more likely to use central data processing and double data 
entry. In addition, the upper mode of the batch-cleaned data, with the exception of one data 
point, consisted of medical record abstraction studies.    
 
Discussion 
Over the last 30 years, empirical data accuracy assessments have been reported in the literature.  
Although there have been articles that summarized results reported in multiple papers 
16
Journal of the Society for Clinical Trials
Clinical Trials
For Peer Review
[5,13,21,22], there has been little synthesis, and this area of inquiry still lacks a theoretical 
framework. Further, although notable exceptions exist [11,22,33,59,79,84,85,87,92], little 
evidence has been obtained regarding the relative accuracy of different data processing methods. 
Characterizing the factors that affect data accuracy, as well as the differences in accuracy among 
popular methods (as done inductively here), serves as the beginning of such a framework.   
 
Medical record abstraction 
First and foremost, our results indicate that medical record abstraction is associated with error 
rates an order of magnitude greater than that attributable to “downstream” data processing 
techniques. These results support claims that medical record abstraction is the most significant 
source of error in clinical research [21,125]. This is unfortunate, because medical record 
abstraction remains the dominant method of data collection in retrospective and prospective 
research, as well as in the fields of safety surveillance and healthcare quality improvement.  
 Although position papers and reports of empirical results exist, the reasons for high error 
rates associated with medical record abstraction have not been systematically studied, and the 
mechanisms are not understood. Empirical studies suggest that there is significant variability in 
the abstraction and quality control processes used [126,127]; these different methods, process 
aids and quality control activities could be responsible for the amount of variation observed. 
Likewise, the reliance on human performance and associated underlying cognitive processes 
could be responsible for some or all of the variability.  
 Several authors have further explored these underlying reasons for the high variability in 
abstraction [56,81,125-129]. Differences related to therapeutic area, such as type of data 
collected, patient acuity, and chart complexity, are one source of variability [81,129]. 
17
Journal of the Society for Clinical Trials
Clinical Trials
For Peer Review
Additionally, variables recorded at multiple time points and at multiple places in the patient 
chart, as well as those that require the abstractor to interpret or synthesize information into a 
score, are known to be more subject to error [81], as are variables requiring the use of clinical 
judgment on the part of the abstractor [128]. Further, although many investigators proceed on the 
premise that charts provide correct data [130], there are a significant number of errors, 
inconsistencies, and omissions in the charts themselves [126,130]. Such chart errors, while not 
arising from abstraction, nonetheless further increase the variability in abstracted data, and are 
not measured or accounted for by current data quality assessment practices [129]. Exploring the 
causes of this variability is an important area for future research. Unfortunately, while there are 
sufficient data points, there is insufficient information in the literature about the medical record 
abstraction methods to further investigate possible causes for the variability in a subgroup 
analysis. 
 Importantly, medical record abstraction errors are less likely to be detected by downstream 
data processing such as data entry or programmatic data cleaning. For example, an incorrect but 
plausible value chosen from the medical record will not be detected by valid range checks.  
Medical record abstraction errors that result in plausible values will only be detected through 
comparison to the medical record; i.e., re-abstraction, while errors in the medical record itself 
will likely remain undetected by this method. 
 Although differences in medical charts among sites complicate the construction of 
abstraction guidelines for multicenter research, differences between abstractors are so significant 
that most authors have recommended and employed detailed abstraction guidelines for each 
variable [56,81,125-128]. Abstraction guidelines are used in national performance measurement 
and healthcare quality improvement programs, such as the Joint Commission specifications for 
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performance measures [131,132] and the Healthcare Effectiveness Data and Information Set 
(HEDIS) roadmap [133].  
 However, such guidelines, which constitute a primary mechanism for preventing abstraction 
errors, are not often used in clinical trials. Instead, less specific form-completion instructions are 
employed. These instructions often do not specify from where in the medical record a particular 
value should be obtained, or provide guidance in the case of multiple available or missing values. 
In a process called source data verification, data for a sample of subjects are compared to the 
chart, typically without calculating an error rate [81,134]. It is unfortunate that the association of 
clinical trials with prospective data collection further fuels the perception that abstraction or 
chart review is not a factor in data accuracy when in fact the chart is the source of most clinical 
research data, and abstraction from the chart is the part of the data collection process most 
subject to error [21,125].  Despite recommendations for measuring and monitoring data quality 
from the medical record abstraction process [29,127,128], abstraction error usually remains 
unquantified [29,40,81,134].   
 
Optical methods 
Although methods such as optical character recognition (OCR) and optical mark recognition 
(OMR) have been touted as a faster, higher-quality or less resource-intensive substitute for 
manual data entry [27,58,62,84,92,93,135-137], others have reported error rates with optical 
methods that were three times higher than manual keyboard data entry [138]. As was the case 
with medical record abstraction, optical methods were associated with a variability of three 
orders of magnitude in accuracy, which is clearly unacceptable for a data entry method. Such 
variability may be influenced by: the presence and type of data cleaning employed in processing 
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the optical scans; use of post-entry visual verification or pre-entry manual review; training of 
form completers on handwriting; differences in form compatibility with the software; software 
configuration (e.g., recognition engine); and variations in data quality assessment methods. For 
example, some implementations employ programmatic checks and visual verification of fields 
labeled with low confidence from the OCR or OMR engine.  In addition, the different engines 
employed need to be calibrated for each implementation.  
 Reports on the accuracy of optical methods uniformly showed greatest accuracy with mark 
objects (check boxes, fill-in-bubbles), followed by numeric fields [27,92,138]. The accuracy of 
free-text fields was the lowest of the three field types [58,92,138]. Some authors have reported 
comparisons of optical methods with double or single data entry [32,62,92,138]; however, 
because of the variability in the reported accuracy, together with the relative paucity of reports 
and the lack of sufficient detail regarding associated data processing methods, we did not 
summarize these findings separately. The results here suggest that with appropriate adjunct data 
cleaning processes, optical methods can achieve comparable accuracy to single-entered data. The 
wide variability also suggests that an a priori quantitative assessment of data accuracy and total 
cost is necessary when an optical system is newly installed or upgraded.       
 
Keyboard entry  
A review of the literature provides the opportunity for analyzing different variations on key 
entry, including single entry, single entry with on-screen data checks, and double entry. We 
undertook these comparisons because single entry is widely used with Web-based EDC, the 
extent of OSCs is at the discretion of the study team, and there is little evidence to guide practice.  
Our analysis demonstrates that single entry with OSC is associated with accuracy comparable to 
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that obtained with double data entry. However, single entry alone was associated with an average 
of more than 100 errors per 10,000 fields, compared with an average of 23 errors per 10,000 
fields with OSC. The subgroup analysis of single entry provides a plausible explanation for the 
variability. This is an important finding, because large amounts of data are collected from 
research sites via Web-based systems, including entry of abstracted data into Web-based 
systems, clinicians entering data in electronic health records, and data collected directly from 
patients via hand-held devices. Due to the problem of “alert fatigue,” however, OSC may not be 
feasible in electronic medical records, where clinical alerts will often be a higher priority. The 
question of alert fatigue in these systems is an important topic for further research. 
 
Central versus distributed  
Given the movement toward Web-based EDC and the use of electronic medical record data in 
clinical research, the question of the relative accuracy between data entered centrally versus 
distributed data entry is an important one. Our results show that in the presence of OSCs, data 
entered centrally have marginally better accuracy compared with data entered at investigational 
sites. However, with the exception of one outlier, the points for distributed data entry fell within 
the range of the centrally entered data. Given the variability in implementations of OSC (e.g., 
number and type of checks), these results suggest that data quality equivalent to that of centrally-
entered data can be obtained through distributed methods, and that more information is needed to 
guide practice.  
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Batch data cleaning  
Batch data cleaning was associated with a decrease in error rates of more than 300 errors per 
10,000 fields, as well as an almost 50% decrease in variability. In addition, an internal analysis at 
our institution noted that on average, values for 1%–2% of any variable changed based on batch 
data cleaning. Although this number was based on programmed batch checks and double entered 
data, the number is consistent with the results from the literature review, and likely to be 
considerably higher for single-entered data. However, as noted earlier, use of batch data cleaning 
was reported in only 19 of the cases reviewed in this analysis (manuscripts that did not report 
batch cleaning were conservatively assumed not to have used it). Importantly, batch data 
cleaning is resource-intensive to implement, because it requires programming logic for each 
suspected discrepancy, the number of which are exponentially combinatorial with the number of 
data fields collected. In addition, the asynchronous identification of data discrepancies (i.e., after 
data entry) necessitated by batch data cleaning also adds a costly feedback cycle, often involving 
multiple iterations, with the clinical investigational site. Batch data cleaning also suffers from 
variability in implementation, including number and type of checks programmed, type of data 
checked, and number of iterations with sites. For these reasons, registries and quality 
improvement reporting do not routinely use batch data cleaning, and the costs of batch data 
cleaning (cited at $35–$100 per discrepancy for paper-based trials [139-141]), has led to their 
utility being questioned in the context of multicenter clinical trials [141]. 
 
Relative accuracy differences between methods  
The amount of overlap in the quality levels across data processing methods suggests that 
different data processing methods or combinations thereof can achieve comparable accuracy.  
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Data cleaning methods that are applied during or after data entry, while creating additional costs 
and user burdens, are likely to increase the accuracy obtainable from a data entry method. For 
example, use of OSCs was associated with lower error rates and lower variability, whether data 
were entered at clinical sites or at a central data center. Additionally, distributed data entry with 
OSCs was associated with error rates similar to those obtained from double-entered data. This 
could be attributed to the proximity to source information where data are entered at clinical 
investigational sites. The latter two comparisons are critical, because adoption of Web-based 
EDC necessitates single data entry at clinical investigational sites. The information presented 
here should prompt those using EDC to fully utilize OSCs. 
 Perception of acceptability regarding different error rates varies from “10% is good” to “1% 
is good” to “there should be no errors [6,20,38].” The answer to the question, “How clean is 
clean enough?” is multifaceted. The effect of errors is dependent on the variable in which the 
errors occur, the number and extent of the errors, and the robustness of the analytical method 
[43]. Based on simulations showing an approximate reduction in statistical power of 1% for each 
additional percent of the error rate [23,41,42] and the analytical work of Rostami et al [40], the 
abstraction error rates seen in the published literature are high nough to impact upon the 
decisions made using the data. Abstraction is a crucial method of data collection, and will remain 
so until data in the healthcare setting are sufficiently standardized to support automated 
extraction from EMRs. Until that time, data will continue to be manually extracted from both 
paper and electronic records. The association of abstraction with high error rates and significant 
variability, as noted here, supports recommendations that both abstraction methods and measures 
of accuracy should be reported with the results from studies employing medical record 
abstraction [126,127]. 
23
Journal of the Society for Clinical Trials
Clinical Trials
For Peer Review
 
Limitations 
 This study is a secondary pooled analysis of database error rates in the published literature. 
Although it constitutes a critical contribution in synthesizing a very fragmented literature base, 
there are many limitations inherent in our work. First, there is the possibility that we may have 
missed relevant articles. Second, because our work is a secondary analysis, it relies on data that 
were collected for other purposes. Although we used error and field counts reported in the 
literature, prior work has shown that even these have significant variability [37,38]. For example, 
some may count dates as discrepant if there is not an exact match, while others may allow a 
window of several days; field counts may exclude null fields, or include fields entered once and 
propagated to multiple places. Results presented here should be examined in this context. Third, 
a lack of standard terminology for data processing methods potentially affects this analysis 
through high likelihood that relevant manuscripts were not identified as mentioned above, and 
also through misinterpreting the information presented in the source manuscripts.  Fourth, due to 
the small number of data points in some subgroups, comparisons between data cleaning methods 
are less reliable than for the four higher-level categories of data processing methods. Fifth, some 
of the articles we included in our analysis reported an assessment of only a few variables, while 
others analyzed many variables or an entire database. Given the observed variability in data 
quality for different therapeutic areas, likely driven by the differences in the type of data, reports 
of error rates on only 1 or a limited number of variables are less generalizable. Sixth, most of the 
articles in our review were from academic organizations and government or foundation-funded 
endeavors that employ different data collection and management methodologies. Although over 
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the time span of the literature we reviewed, those methods have tended to converge, our results 
may be less applicable to industry funded studies.  
 Given these limitations, we draw conclusions only about associations and trends.  
Importantly, although there is strong correlation between data processing method and both 
central tendency and dispersion of data error rates, this association does not imply causality, and 
other important factors not assessable here may be responsible for these results. Other possible 
explanations for the variability seen here include variations in local system implementations and 
workflows, the number of data processing steps, differences in reporting error rates, skill level of 
the staff, and complexity of the data. These factors were not assessable in a literature review such 
as ours. The inability to measure or control for these possible alternatives represents a weakness 
in this analysis, and they remain topics for further investigation. 
 
Further research  
The published information on data quality derives mainly from evaluation and observation of 
data accuracy in funded registries and clinical trials, as opposed to targeted experimental inquiry.  
While a biannual conference on cross-industry data quality exists [142], and a clinical research-
focused Data Quality Research Institute was founded in 2004 [143], funding for dedicated data 
quality research has remained slim or non-existent; therefore, there are few controlled 
experiments evaluating data capture or cleaning methods to date and even less generalizable 
work contributing to the body of knowledge. Research from multiple epistemological stances 
would provide valuable information to confirm or challenge the trends identified here. Further, 
as data (increasingly captured electronically) are used to support direct patient care, performance 
measurement, and research, the effects of data quality on decision-making need thorough 
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exploration, as do the effects of system usability and data entry and cleaning methods on data 
quality and clinical workflow.  
 
Conclusions  
The formal literature on clinical research data quality remains significantly fragmented. 
Standardizing terminology and using it to index the literature base may lead to wider recognition 
of the applicability of data quality work within clinical research and biomedical informatics and 
provide amalgamation points. Importantly, the results presented here, while gained from a 
secondary analysis, are of immediate use in informing investigators and research teams of the 
options and characterization of common data collection and processing methods with respect to 
data accuracy. In particular, the variability if not the magnitude of error rates reported should 
encourage evaluation of the impact of new technology and processes on data accuracy, and 
subsequent decisions regarding whether the accuracy is acceptable for the data’s intended use. 
 In synthesis, we suggest that data quality varies widely by data processing method. Further, it 
appears that the lowest-quality process, abstraction, is the most ubiquitous and also the least 
measured and controlled within research projects. Although th y pale in comparison to 
abstraction error rates as a source of variability, the differences in accuracy of data entry methods 
also deserve consideration. On average, double data entry provides the highest accuracy and 
lowest variability, followed by single entry. Of all popular data entry techniques, optical methods 
provide the lowest data quality and the highest variability. However, other confounding factors 
assessed, including use of OSC with single data entry, and batch data cleaning checks, as well as 
factors not identifiable or assessable in a secondary analysis (e.g., staff experience, number of 
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manual steps, and data complexity), may constitute substantial mediators with the potential to 
equalize differences between methods.   
 Error rates reported in the literature are well within ranges that could necessitate increases in 
sample sizes from 20% or more in order to preserve statistical power for a given study design 
[144,145]. Data errors have also been shown to change p values [44] and attenuate correlation 
coefficients to the null hypothesis [42,146,147]; in other words, a given clinical trial may fail to 
reject the null hypothesis because of data errors rather than because of a genuine lack of effect 
for the experimental therapy [149]. In the presence of large data error rates, a researcher must 
then choose to either 1) accept unquantifiable loss of statistical power and risk failure to reject 
the null hypothesis due to data error; or 2) measure the error rate and increase the sample size to 
maintain the original desired power [40,145,147]. The adverse impact of data errors has also 
been demonstrated in registries and performance measurements [121,149-154], as has failure to 
report data [155].  
 While such results in aggregate are shocking, we do not present them to incite panic or cast 
doubt upon clinical research results. Other factors that are not assessable here, such as variables 
in which the errors occurred, and statistical methods used to take the measurement error into 
account, are necessary for such assessments. We applaud the authors of the reviewed papers for 
their rigor and forthrightness in assessing error; measurement is the first step in management. We 
hope that our analysis makes a strong and convincing argument for the measurement and 
publication of data accuracy in clinical research. 
 While there is general agreement that the validity of research rests on a foundation of data, 
data collection and processing are sometimes perceived as menial and peripheral to the core 
operations of caring for patients or completing a clinical research project. In between rote data 
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entry and scientific validity, however, lie many unanswered questions, which, if answered, will 
help investigators and research teams balance cost, time and quality while assuring scientific 
validity.   
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Figure legends 
Figure 1 Chronology of the database error rate literature. 
Figure 2 Data error rates for data processing methods. Error rates, medians and 95% confidence 
intervals are displayed with a logarithmic axis. The medical record abstraction process is 
associated with the largest and most variable error rate.  Similarly, optical methods, such as 
optical mark recognition (OMR) and optical character recognition (OCR) as well as single data 
entry show variability that spans more than one order of magnitude. 
Figure 3 Subgroup analysis for single entry. Error rates, medians and 95% confidence intervals 
for cases reporting single entry. The impact of location of data processing and the impact of on-
screen (i.e., at the point of entry) error checking were examined. Location had little effect on data 
accuracy, while presence of on-screen error checks was consistently associated with a decreased 
error rate. 
Figure 4 Error rates for single-entered data in the presence of on-screen error checks. Figure 4 
displays error rates, medians and 95% confidence intervals for single-entered data in the 
presence of on-screen error checks. This combination most closely resembles today’s Web-based 
EDC process and shows that the EDC model is likely capable of producing data of comparable 
data processing accuracy to paper-based methods. 
Figure 5 Subgroup analysis for batch data cleaning. Error rates, medians and the 95% 
confidence intervals from the sub-group analysis for batch data cleaning are displayed. As 
expected, batch data cleaning was associated with a lower error rate. In addition, the upper mode 
of the batch cleaned data consisted of medical record abstraction studies, showing that in-house 
batch data cleaning is most likely not capable of identifying and correcting errors created in the 
medical record abstraction process. 
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Table 1 Sources of articles 
Journal Number of 
Articles 
Controlled Clinical Trials/Clinical Trials Journal 17 
American Journal of Epidemiology 4 
Journal of Clinical Epidemiology 3 
Journal of the American Medical Informatics Association (AMIA) or AMIA 
Proceedings 
3 
International Journal of Epidemiology 2 
Computers in Biomedical Research 2 
International Journal of Quality in Healthcare 2 
European Journal of Cancer 2 
Journal of Clinical Oncology 2 
Scandinavian Journal of the Society of Medicine 2 
Journal of Trauma Infection and Critical Care 2 
Pediatrics 2 
Various medical specialty and informatics journals contributing one article 48 
Total 93 
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Table 2 Categorization of articles used in this review 
Literature Categorized by Type of Secondary Use and Data Processing Method 
Reports of operational accuracy assessments to determine the usability of administrative 
databases for research or surveillance [45-50] 
Reports of database quality control in clinical trials where gold standard was the medical record 
[12,15,20,24,51-56] 
Reports of quality control in epidemiological, survey or observational studies where the gold 
standard was the medical record or taped interview [46,57,62] 
Reports of instrument validation studies where the gold standard was the medical record or 
patient self report [63,64]   
Reports of database quality control in research or quality improvement registries where gold 
standard was the medical record [13,50,57,65-78]   
Reports of stand alone data processing studies using clinical trial-type forms and processing 
[11,33,64,79,80]   
Reports of medical record abstraction evaluation [12,56,77,80,81] 
Reports of clinical trial data processing quality that used the Case Report Form or other data 
processing step as  the gold standard in a comparison to the trial database [7-
10,22,25,41,59,79,82-96] 
Reports of database quality control in surveillance registries [48,49,94,97-120] 
Reports of data accuracy assessments of other health-related primary or secondary data uses 
[32,47,94,121,122]   
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Table 3 Data processing dimensions 
Processing dimension Description 
Location of data processing Whether data were entered and cleaned at a central 
data center or a local healthcare facility 
Central coordinating center Data center receiving and processing data from 
multiple sites. A healthcare facility does not qualify 
as a data center. 
Local research site or healthcare 
facility 
Location or institution where data were collected 
Type of entry Method used to convert data to electronic format 
Single One person enters data once 
Double Two different individuals enter data. Distinction was 
not made between different types of double data 
entry. 
Optical mark/character recognition  Data on paper forms were optically scanned into 
electronic format 
Source from which data were 
entered 
Physical representation (if any) that the data enterer 
looked at during data entry 
Medical record (paper chart) Paper documentation of patient care produced and 
maintained by a healthcare facility 
Electronic medical record Electronic documentation of patient care produced 
and maintained by a healthcare facility 
Paper data collection form Structured data collection form completed by 
healthcare or research staff 
Live interview or ePRO Patient recall and direct electronic report 
Image displayed on computer 
screen 
Electronic representation of a data collection form 
rendered on a computer screen 
Type of error checking* Method, if any, used to clean data 
On-screen during data entry Real-time error checks that run during data entry 
Post-entry batch computerized 
checks 
Computerized error checks run after data entry, 
usually nightly 
Visual verification Manual comparison of entered data to the entry 
source 
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Table 4 Dimensions of data quality assessment 
Process being measured 
Source to database: process from medical record to database, including abstraction, data 
entry, and cleaning. 
Source to data collection form: abstraction process from medical record to data collection 
form. Does not include data entry and cleaning. 
Data collection form to database: process includes data entry and cleaning. 
Single entry: only process measured is one entry of data. 
Type of database assessed 
Healthcare administrative database: coded data intended for use in billing. 
Registry database: secondary database including phase 4 trials, surveillance programs, 
quality improvement and disease registries. 
Trial database: secondary dataset collected for a clinical trial. 
Case report form or data collection form: structured data collection form; secondary data. 
Computer aided interview / Patient self report: dataset containing patient reported data via a 
computer.  
Method of Measurement 
Comparison to a “gold standard”: manual comparison of two datasets from different sources or 
two different points in a process. 
Independently re-processing data: data processed from the same source by an independent 
individual. 
Linking and comparing data electronically: electronic comparison of two separate databases. 
 “Gold Standard” for comparison 
Medical record (paper or electronic): paper or electronic documentation of care produced and 
maintained by a healthcare facility. 
Independent or taped patient self-report: patient recall and direct electronic report.  
Data collection form: structured data collection form completed by healthcare or research staff. 
Independent database: database created from a separate source. 
Data Independently entered from same source  
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Table 5. Descriptive statistics by data processing method 
  Median Mean SD Min Max 
Abstraction 647 960 1018 70 5019 
Optical 81 219 337 2 1106 
Single Entry 26 76 150 3.8 650 
Double entry 15 16 10 3.5 33 
SD = standard deviation
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Table 6a Descriptive Statistics for Single Entry Subgroup Analysis 
 Mean Median SD Min Max 
Central 77 30 143 4 650 
Distributed 86 25 175 15 550 
Distributed, no on-screen checks 550 550 * 550 550 
Distributed, On-screen Checks 28 24 17 15 69 
All no on-screen checks 158 52 211 4 650 
All with on-screen checks 23 22 15 4 69 
*There was only one value for distributed single entry with no on-screen checks 
SD = standard deviation 
 
Table 6b Descriptive statistics for central versus distributed data processing  
in the subset of articles reporting use of on-screen checks 
 
Mean Median SD Min Max 
Central 19 17 12 4 39 
Distributed 28 24 17 15 69 
SD = standard deviation 
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Table 7 Descriptive statistics for batch subgroup analysis 
 
Mean Median SD Min Max 
No batch data cleaning 
reported 648 270 946 2 5019 
Batch data cleaning reported 306 36 428 2 1351 
SD = standard deviation 
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Chronological Survey of the Database Error Rate Literature
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Defining Data Quality for Clinical Research:  
A Concept Analysis 
 
 
Despite notable previous attempts by experts to define data quality, the concept remains 
ambiguous and subject to the vagaries of natural language. This current lack of clarity continues 
to hamper research related to data quality issues. We present a formal concept analysis of data 
quality, which builds on and synthesizes previously published work. We further posit that 
discipline-level specificity may be required to achieve the desired definitional clarity. To this 
end, we combine work from the clinical research domain with findings from the general data 
quality literature to produce a discipline-specific definition and operationalization for data 
quality in clinical research. While the results are helpful to clinical research, the methodology of 
concept analysis may be useful in other fields to clarify data quality attributes and to achieve 
operational definitions. 
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1. INTRODUCTION 
The most common definition for quality, including data quality, is “fitness for use” [Batini and 
Scannapieco 2006; Lee, Pipino, Funk and Y. 2006]. This broad definition abstracts across 
differences among industries and focuses attention on the customer; both attributes are 
beneficial. However, the corresponding lack of definitional specificity precludes use in research, 
as well as operationalization within specific disciplines. Citing Juran’s “fitness for use” 
definition, the American Society for Quality acknowledges both high-level and discipline-
specific needs and defines quality as “a subjective term for which each person or sector has its 
own definition” [Quality Progress Editorial Staff 2008]. This formulation implies that employing 
a more abstract definition without refining its application within the specific discipline of data 
quality could have detrimental effects.  
Successful theoretical development requires well-defined concepts. It is incumbent upon 
researchers within disciplines to define concepts with specificity capable of supporting scientific 
inquiry in the context of overarching theory. The purpose of this work is to clarify the term 
clinical research data quality for use in theory development, research, and application to 
operations. Simply put, we cannot test a poorly defined theory, nor manage what we cannot 
measure [Redman 1996].  
 
2. BACKGROUND 
2.1. Clouding Factors 
There is ample reason for the fuzziness that has historically surrounded the concept of data 
quality. Most authors define data quality as a multidimensional concept with dimensions that 
include categories such as accuracy, currency, consistency, and completeness [Batini et al. 2004; 
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Batini and Scannapieco 2006; Pipino et al. 2002; Redman 1996; Tayi and Ballou 1998; Wand 
and Wang 1996; Wang and Strong 1996]. This multidimensionality (multiple attributes), 
however, can lead to ambiguity and imprecision because different groups may emphasize some 
dimensions while excluding others.  
For example, the information technology (IT) sector defines data quality by conformity to 
data definition and stated business rules, while regulatory and legal groups tend to emphasize 
attribution and verifiability [U.S. Food and Drug Administration 2007]. It is likely that in many 
contexts only a subset of attributes will be considered important; thus, proliferation of use-related 
and use-specific definitional subsets will continue. Further complicating matters, data quality has 
dimensions that are inherent to the data, such as accuracy, and dimensions that are context 
dependent, such as timeliness and relevance [Lee et al. 2002; Wand and Wang 1996]. Moreover, 
even inherent characteristics may be relative; i.e., what constitutes good quality for some uses 
may be poor quality for others [Ge and Helfert 2007; Wand and Wang 1996].  
Additional confusion exists between data quality and related concepts. For example, 
inherent characteristics of data (e.g., volatility and accessibility) have been used as dimensions of 
data quality. Likewise, attributes of the systems used to store and provide access to data are 
sometimes referred to as data quality dimensions, obscuring the distinction between data and 
system [Redman 1996]. For example, suboptimal system usability, implementation choices, or 
data structure may be construed as data quality issues.   
 
2.2. Prior Attempts to Clarify the Concept of Data Quality 
In spite of the efforts of experts in the field, the concept of data quality remains elusive. Some 
texts do not define data quality [Liepins and Uppuluri 1990; Maydanchik 2007; Naus 1975], 
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while other works adopt the generic (and abstract) “fitness for use” definition [Herzog et al. 
2007; Olson 2003; Redman 1996; Redman 2001]. Lee and colleagues [2006] state that data 
quality should be defined in the context of the organization, using applicable dimensions from 
the literature, but they do not provide examples. Still others provide multiple definitions, or 
simply note that there “is no general agreement either on which set of dimensions defines data 
quality or on the exact meaning of each dimension” [Batini, Catarci and Scannapieco 2004].   
Quality dimensions are similarly diverse and have been classified into three broad 
categories: 1) intuitive approach; 2) empirical approach; and 3) theory-based approach [Batini, 
Catarci and Scannapieco 2004], with each category ranked according to number of citations 
[Wand and Wang 1996]. The association of the same term to different definitions characterized 
by Batini [2006] indicates that progress toward a consensus dimension-based definition is still 
hindered by vagaries of natural language and idiosyncratic usage. Importantly, with the 
exception of Orr’s System Theory work, Wand and Wang’s ontological work, and Frank’s 
ontological work specific to the geospatial mapping domain [Frank 2007; Orr 1998; Wand and 
Wang 1996], the concept of data quality has not been linked to theory.  
Where specificity can not be obtained for an entire field (as in the case of data quality), it 
may be possible within a specific sector [Batini and Scannapieco 2006; Quality Progress 
Editorial Staff 2008]. Accordingly, we sought to achieve a discipline-specific definition and 
attribute list for clinical research data quality that accommodates the context of broader data 
quality work. 
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2.3 Needs of Clinical Research 
Research data management is an exercise in mass customization [Koh 2008]. A clinical trial 
database is considered a product; the customers are the statisticians analyzing the data and the 
clinical community interpreting the results. The data collected and the level of quality 
appropriate for each variable both depend on the scientific question(s) being asked and the 
statistical tests applied in each study—one study’s major independent and dependent variables 
and important covariates might be only background supporting data for another study.   
Necessary data quality als  depends not only on which variable/s are in error, but also on the 
degree of robustness of the statistical analysis to those errors [Nahm et al. 2008].  
Because the development of clinical knowledge often entails combining data from 
different studies, or from studies managed by different organizations, a consistent definition of 
data quality and standard ways of measuring it are critical [Nahm et al. 2004]. As these needs are 
discipline-specific, a correspondingly specific definition for clinical research data quality may be 
appropriate. Such a definition, however, should remain compatible with the context of the 
research done in the broader data quality domain.  
 
3.  METHODS 
We performed a systematic concept analysis using the method of Walker and Avant, in which a 
concept is clarified through explication of antecedents, consequences, attributes, and cases 
[Walker and Avant 2005]. Due to the richness of work in data and information quality and our 
desire to preserve that broader context, we approached our project as a concept derivation rather 
than a de novo concept synthesis [Walker and Avant 2005]. Although clinical research data 
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quality shares dimensions with the more generic term used in IT and data warehousing, the 
importance and definition of the dimensions differ, as does the unit for decision-making.  
Following Walker and Avant, attributes (called dimensions in the data quality literature), 
were identified through a review of the general data quality literature that used the Google 
Scholar™ search engine to identify relevant articles. Due to the large number of results retrieved 
(218,000 citations for “data quality” and 43,800 citations for “data quality” AND “theory”), we 
focused on review papers and published books. Attributes from the literature applicable to 
clinical research were selected and categorized. Where possible, literature definitions were used, 
although in some cases there were significant conflicts in definitions across various sources 
[Batini and Scannapieco 2006].   
 
3.1. Uses of the Data Quality Concept 
While business, IT, and manufacturing sectors tend to favor the “fitness for use” definition of 
data quality, the term has been used in clinical research to denote accuracy of the data; i.e., the 
extent to which the data reflect the true state of the patient. The Institute of Medicine defines 
quality data as those that “support the same conclusions as error-free data” [Institute of Medicine 
1999]. In previous work, Nahm et al.  applied the label data quality to what was in fact a measure 
of data accuracy [Nahm, Pieper and Cunningham 2008]. To a greater extreme throughout the 
clinical research industry, the result of a data quality assessment refers to a narrow scope, such as 
fidelity of data processing or compliance in measuring, observing, or collecting data [SCDM 
2007]. In clinical registries, data quality refers to a subset of dimensions, most commonly 
accuracy and completeness [Arts et al. 2002]. In IT, data quality incorporates conformity to 
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syntactic constraints, as well as accuracy and completeness [Herzog, Scheuren and Winkler 
2007; Naus 1975]. 
The term quality itself is problematic. Merriam-Webster’s Dictionary lists eight 
definitions for quality (Figure 1), aspects of which are to be found in technical usage (e.g., 
degree of excellence; inherent feature; distinguishing attribute). Similarly, the definition of data 
remains a topic of academic debate [Johnson 2008]. One school of thought posits data as a 
difference (for example, a black dot on a white page constitutes data), and that data plus meaning 
create information [Floridi 2008]. Coiera, [2003] on the other hand, considers data the raw form 
of information.  
[Figure 1. Caption set underneath illustration.] 
As with the term quality, these differing definitions and interpretations cloud the term 
data (Figure 2).  
[Figure 2. Caption set underneath illustration.] 
For example, if we adopt the first Merriam-Webster’s definition (factual information), the output 
of aggregate reports would constitute data, and thus the concept of data quality should apply at 
the aggregate level. Others, adopting a Floridian or Coieraian interpretation, likely would not 
apply the concept of data quality to an aggregate report. Additionally, meaning is a pivotal point 
between the Coieraian and Floridian definitions. One possible attribute of data quality is 
specificity (non-ambiguity), which requires meaning to accompany data, and implies that it is not 
data quality that we should be concerned with at all, but rather information quality.   
  Definitional work to date has not yielded the clarity needed for theoretical development 
and research. Because scientific and operational use of a concept requires focus and precision, 
this work proceeds with the scientific and operational uses of the term data quality. 
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3.2. Antecedents and Consequences 
Data quality has a number of necessary precursors. First, there must be data, as defined by 
Floridi [2008] or Coiera [2003]. Second, data must possess attributes sufficient for us to 
recognize them as the particular data of interest. Interestingly, the more we know about data, the 
more they approach the Floridian definition of information; thus, the difference between data 
quality and information quality, if one exists, is not illuminated by this analysis. Third, there 
must be a representation of data such that humans or machines can recognize and process them.  
Fourth, there must be a source for comparison so that the quality or dimension of data quality can 
be judged (i.e., a concept of truth, correct value, or reference point).  
The ultimate consequence of data quality in the Juran sense is that the data are fit for the 
customer’s use. In clinical research, data that possess quality “support the same conclusions as 
error [blemish] free data” [Institute of Medicine 1999]. (The term blemish was added to account 
for the dimensions in addition to accuracy that effect data use and usefulness.) Importantly, 
Juran’s “fitness for use” definition is broader than the IOM’s. In clinical trials, when a 
statistician decides whether available data can be used for an analysis, he or she is applying the 
IOM definition. 
 
3.3. Dimensions 
Data quality dimensions are data characteristics that affect use and usefulness; further, they are 
the mechanism through which we design, control, and increase data quality [Tayi and Ballout 
1998]. The dimensions deemed necessary for clinical research—accuracy, currency, 
completeness, consistency, timeliness, relevance, granularity, specificity (non-ambiguity), for 
precision, and attribution were chosen from the literature (Table I) and used whenever possible.  
[Table I. Table head on top of table.] 
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Where literature definitions did not provide an adequate fit with clinical research use, discipline-
specific definitions were created. Also provided in Table I are operational definitions or metrics 
for definitions.   
Of note, defining dimensions at the level of measurable metrics helped clarify a 
confounding factor characteristic of clinical research: while some dimensions may be assessed at 
the data value level (e.g., correct vs. incorrect); in clinical research, decision-making occurs at 
the database level (i.e., “Is this database of adequate quality to support the analysis?”). This 
database-level information is derived by aggregating value-level results (for example, number of 
errors divided by number of data values) and differs from the broader data quality methodology 
of value-level assessment and decisions. 
As with the broader data quality field, clinical research requires both inherent and 
context-sensitive dimensions; for example, “timeliness” for expedited safety event data differs 
from the “timeliness” of database lock. We accommodated this issue by providing an operational 
definition or measure, while leaving the acceptance criterion context-specific. In the case of our 
example, “timeliness” is operationally defined as the difference between the date the data are 
needed and the date they are available. The acceptance criterion (i.e., the definition of 
“excessively late”) is left to the customer. To clarify these different dimensions, Table I labels 
each dimension as inherent or context-sensitive and provides a context-sensitive operational 
definition.  
Importantly, while inherent dimensions can be defined and assessed independently of 
context, operational definitions for context-sensitive dimensions depend upon the intended use.  
Thus, inherent dimensions can be stored as value-level or dataset-level metadata (i.e., with data, 
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as advocated in several texts), whereas context-sensitive attributes by definition must be assessed 
at time of use [Batini and Scannapieco 2006; Lee, Pipino, Funk and Y. 2006].  
This approach differs significantly from others in that the assessment, although counted 
on a data value-level basis, does not provide a data value-level metric for each dimension that 
can be stored with each data value. In clinical research, data quality is defined based on these ten 
dimensions as “dimensional metrics meeting the acceptance criteria of the data user and 
consumer.”   
 
3.4 Illustrating Cases 
3.4.1 Ideal Case 
A directory of research projects that contains descriptive information about each project was 
created as a searchable inventory to aid in identifying scientific collaborations. A researcher 
seeking potential collaborators for a cell therapy study queries the database and retrieves three 
projects. Two of the projects are hers, and she recognizes that the information is accurate, 
consistent, and complete. She also notes that her study coordinator has been maintaining the data 
and that it is current. The third project belongs to another researcher, indicating a potential 
collaborator. In this case, the data were available when needed, were relevant to her question, 
and provided a sufficient level of detail to answer her question; therefore, the data are of high 
quality. 
 
3.4.2 Contrary Case 
A researcher uses data from a similar directory at another institution to find potential 
collaborators for a cell therapy study. He queries the database and retrieves two projects, but 
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immediately suspects the data are incomplete, inaccurate, and inconsistent because one of his 
own projects is missing, and another is listed as belonging to the incorrect investigator. Upon 
closer examination, he is unable to tell who entered the erroneous data or when it was last 
updated. One of the two returned projects belonged to another researcher, pointing him toward a 
potential collaborator. However, it was unclear whether the telephone number listed was for the 
trial call center or the investigator. Not wanting to risk embarrassment, he decided not to attempt 
contacting the potential collaborator. In this case, although data were relevant and at an 
appropriate level of detail, they were inaccurate, unattributed, incomplete, and inconsistent, and 
therefore were not quality data. 
 
3.4.3 Illegitimate Case 
A researcher completes an analysis of a project and provides two tables and a listing to a 
colleague, who glances at the tables and replies, “Wow, nice job. These look great. High quality 
work!” This scenario is not a legitimate example of data quality, because no attributes were 
assessed. The colleague merely examined the table format and not the contents, and used no 
source of comparison for the assessment. In addition, aggregate numbers on a table are not 
always an indicator of data quality; they may be an indicator of programming quality. 
 
3.4.4 Borderline Case 
A researcher downloads transcripts from focus group meetings. After reading the information, he 
determines that the questions used in the groups are not sufficiently relevant to his research 
question and decides that he cannot use the data for his intended purpose. This is a borderline 
case, because relevance is an attribute of data quality. However, it is context dependent, in that 
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the same focus group data were relevant to the original research questions asked. Thus, data may 
not be relevant or at the right detail level for a secondary use, but may have been so for their 
initial use. 
 
4.0  CONCLUSION 
We have advanced a definition for data quality in clinical research that includes the following 
key attributes: accuracy, completeness, currency, consistency, timeliness, relevance, granularity, 
specificity, precision, and attribution meeting the acceptance criterion of the data user and 
consumer. Clarity has been added through explication, differentiation, and definition. This clarity 
was achieved at the expense of generality of application. An operationalizable definition for 
clinical research is a significant contribution, given its potential for supporting related research. 
We were able to use general concept analysis techniques to achieve the desired clarity regarding 
the concept of data quality in clinical research. This analysis, while subject to the same 
limitations of natural language that underlie the original ambiguities, delineates differentiating 
and orthogonal characteristics of data quality attributes (e.g., inherent versus context-sensitive, 
that enable operational definitions. Thus, while the results are helpful to clinical research, the 
methodology of concept analysis may be useful in other fields to clarify data quality attributes 
and to achieve operational definitions. 
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Figure Legends 
Figure 1. Definitions of Quality. From: Merriam-Webster Online Dictionary, 2008 (used with 
permission). 
 
Figure 2. Definitions of Data. From: Merriam-Webster’s Online Dictionary, 2008 (used with 
permission). 
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Table 1. Data Quality Dimensions for Clinical Research 
  
Inherent 
Context 
sensitive 
 
Natural Language Definition 
 
Operational Definition / Metric 
Accuracy Yes No States in the data match the 
intended state in the real 
world (data values represent 
real world truthfully) 
Number of errors divided by 
number of fields inspected 
(implies comparison with a 
gold standard) 
Currency Yes No The length of storage for a data 
value (since last update) 
Date of use/need minus date 
data last updated  
Completeness Yes No The extent to which every 
represented real world state is 
reflected in the data  
Number of missing values 
divided by number of fields 
assessed  
Consistency 
(internal) 
Yes No Where there are multiple 
representations of real world 
states in the data, they are the 
same. For clinical research, 
extended to: data values 
representing the same real-
world state are not in conflict  
Number of discrepant values 
divided by number of values 
subject to data consistency 
checks 
Timeliness No Yes Length of time from a change in 
the real world state to the time 
when the data reflect the 
change 
Date data are needed minus 
date data are ready for 
intended use 
Relevance No Yes Data can be used to answer a 
particular question 
Percentage of data values 
applicable to intended use 
Granularity No Yes Level of detail captured in data Percentage of values at level of 
detail appropriate for intended 
use 
Specificity     
(non-
ambiguity) 
Yes No Each state in the data definition 
(metadata) corresponds to 
one (or none) state of the real 
world  
Number of values with full ISO 
11179 metadata, including 
definition, divided by number 
assessed 
Precision  No Yes Number of significant digits to 
which a continuous value was 
measured (and recorded); for 
categorical variables, the 
resolution of the categories 
Percentage of values with 
precision appropriate for 
intended use 
Attributability Yes No Source and individual who 
generates and updates data 
are inextricably linked to data 
values 
Percentage of data values 
linked to source and user ID 
of person who generated and 
changed the record  
Italicized wording quoted from Wand and Wang 1996.  
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Figure 1. Definitions of Quality. From: Merriam-Webster Online Dictionary, 2008 (used 
with permission). 
Figure 1: Definitions of Quality 
1 a: peculiar and essential character : NATURE <her
ethereal quality> b: an inherent feature : PROPERTY
<had a quality of stridence, dissonance> c: CAPACITY , 
ROLE <in the quality of reader and companion>
2 a: degree of excellence : GRADE <the quality of 
competing air service> b: superiority in kind
<merchandise of quality>
3 a: social status : RANK b: ARISTOCRACY
4 a: a distinguishing attribute : CHARACTERISTIC
<possesses many fine qualities> barchaic b : an 
acquired skill : ACCOMPLISHMENT
5: the character in a logical proposition of being
affirmative or negative
6: vividness of hue 
7 a: TIMBRE b: the identifying character of a vowel
sound determined chiefly by the resonance of the vocal
chambers in uttering it 
8: the attribute of an elementary sensation that makes it 
fundamentally unlike any other sensation
--Merriam-Webster Online Dictionary
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Figure 2. Definitions of Data. From: Merriam-Webster’s Online Dictionary, 2008 (used 
with permission). 
Figure 2: Definitions of Data 
1 : factual information (as measurements or 
statistics) used as a basis for reasoning, 
discussion, or calculation <the data is
plentiful and easily available>
<comprehensive data on economic growth
have been published>
2 : information output by a sensing device or
organ that includes both useful and
irrelevant or redundant information and must
be processed to be meaningful
3 : information in numerical form that can 
be digitally transmitted or processed
--Merriam-Webster Online Dictionary
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Abstract 
Medical record abstraction (MRA) is known to be a 
significant source of data errors in secondary data 
uses. Factors impacting the accuracy of abstracted 
data are not reported consistently in the literature. 
Two Delphi processes were conducted with 
experienced medical record abstractors to assess 
abstractor’s perceptions about the factors. The 
Delphi process identified 9 factors that were not 
found in the literature, and differed with the 
literature by 5 factors in the top 25%. The Delphi 
results refuted seven factors reported in the literature 
as impacting the quality of abstracted data. The 
results provide insight into and indicate content 
validity of a significant number of the factors 
reported in the literature. Further, the results 
indicate general consistency between the perceptions 
of clinical research medical record abstractors and 
registry and quality improvement abstractors. 
Introduction 
As early as 1969, medical record abstraction was 
associated with poorly described processes, 
inconsistency and error1. By 1990, although many 
advancements in data collection for research had 
occurred, MRA was still regarded as problematic2. 
While MRA remains a common method of data 
collection for research and secondary data use3-6, 
recent publications highlight the persistence of data 
accuracy problems7, 8.   
Importantly, MRA has been associated with the 
highest and most variable error rates of common data 
collection and processing methods8. These error rates 
are high enough to cause problems in the use of 
abstracted data8-11. 
This study was conducted to characterize abstractor 
perceptions about what factors impact the accuracy 
of abstracted data. Research questions included: 1) 
What factors do experienced abstractors think impact 
the accuracy of abstracted data? 2) Does experience 
as a clinical research or registry / quality 
improvement abstractor create differences in 
perception? 3) Do abstractor perceptions differ from 
those factors most frequently mentioned in the 
literature? If so, what are the differences? 
Background 
The literature contains several hundred articles about 
medical record abstraction, however, existing work is 
largely a-theoretical. Further, an authoritative 
definition of MRA has not been articulated. The 
following operational definition of MRA is used for 
this research:  A process in which a human manually 
searches through a medical record to identify data 
required for a secondary use. Abstraction involves 
some direct matching of information found in the 
record to the data required, but also includes 
operations on the data such as categorizing, coding, 
transforming, interpreting, summarizing, and 
calculating. The abstraction process results in a 
summary of information about a patient for a specific 
secondary data use.   
While at first blush, extraction of data directly from 
electronic medical records may appear to be the 
solution to accuracy issues in MRA, there are many 
reasons why this is not likely the case12. Computer 
programming resources, and sophisticated data query 
tools, are currently required for such extraction. 
These resources are not available to many 
researchers, and few, if any, tools exist to automate 
components of the abstraction process. Further, 
barriers to accessing such resources may be high, and 
for small investigator initiated studies, the costs 
likely exceed those of manual abstraction. In these 
cases, MRA will still be used and data accuracy from 
MRA will remain a concern. 
Methods 
Two concurrent Delphi13 processes were conducted, 
one with experienced clinical research abstractors 
and one with experienced registry and quality 
improvement abstractors to obtain from the expert 
abstractors a list of factors that impact accuracy of 
abstracted data.  
Abstractors for the clinical research Delphi were 
recruited at the Society for Clinical Research 
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Associates (SoCRA) national conference in 
September 2009. Registry and quality improvement 
abstractors were recruited at the American Health 
Information Management Association (AHIMA) 
National Convention in September 2009.  
Eligible participants were individuals having: 
1. Three or more years of abstraction 
experience as reported by the participant 
2. Abstraction experience in either a clinical 
research or registry / quality improvement 
setting  
3. Able and willing to give informed consent 
 
In the first round, participants were asked to list from 
five to ten factors that based on their experience, 
impacted the accuracy of abstracted data. Following 
Round 1, the factors were reviewed and sorted 
according to semantic matches to obtain a list of 
distinct factors and the number of times each was 
mentioned. 
The Round 1 factors were combined with factors 
obtained from a systematic literature review and 
provided back to the participants in Round 2.  Factors 
were presented as statements that each increased or 
decreased the accuracy of abstracted data. In Round 
2, the participants were asked to rate their level of 
agreement with these statements on a five point likert 
scale (strongly disagree, mildly disagree, neither 
agree or disagree, mildly agree, and strongly agree). 
Only participants who completed Round 2 were 
eligible to participate in subsequent rounds. 
In Round 3, the participants in each Delphi were each 
provided an individualized report of their Round 2 
responses versus the aggregate responses of their 
Delphi. In Round 3, participants were 1) asked for 
more information about factors where their response 
was within one point* of the aggregate and factors 
where their responses differed by more than one 
point from the aggregate, and 2) given the 
opportunity to change their responses should they 
wish to do so.  Requesting participants to tell the 
interviewer more about their responses enabled 
researchers to assure consistent understanding of the 
statements on the Round 2 questionnaire as well as 
provided the researchers more in depth information 
about factors where there were disagreements, i.e., 
where answers depended on things external to the 
statement such as differences in study types, or 
clinical area. 
                                                          
* One point was chosen because a difference of one point is 
the difference between the categories on the likert scale. 
In Round 4 the participants were each provided an 
individualized report of their Round 3 responses and 
the aggregate of their Delphi. In all other aspects, 
Round 4 was conducted in the same manner as 
Round 3.   
Rounds 1 and 2 were conducted using the cogix web-
based survey system. Rounds 3 and 4 were 
conducted via structured phone interview. To prevent 
bias, an interviewer independent from the study team 
was used.  
Twenty clinical research abstractors and 18 registry 
and quality improvement abstractors were consented 
to participate in this research to retain at least seven 
participants in the last round13. The participation rates 
for the rounds are shown in Table 1.  
 Delphi Round 
 1 2 3* 4* 
Clinical Research 80% 85% 68% 68% 
Registry / QI 83% 67% 88% 88% 
* denominator for Rounds 3 and 4 is the number of participants in 
Round 2.  
Table 1. Delphi Participation Rates 
This research was reviewed and approved by the 
Duke University and University of Texas 
Institutional Review Boards. 
Systematic Literature Review 
To inform Round 2, a systematic review of the 
literature was conducted to identify factors as 
impacting the accuracy of abstracted data.  A 
PubMed query†  in October of 2009 identified 361 
articles. Abstracts for the 361 articles were reviewed 
by two people resulting in the exclusion of 287. The 
74 included articles were read in full by two 
independent people.  One hundred and thirteen new 
articles and technical reports were identified from 
citations in the reviewed articles, resulting in 187 
articles reviewed. Of the 187 reviewed articles, 37 
were subsequently found not to meet the inclusion 
criterion, leaving 150 articles ultimately included in 
the review. The inclusion criterion for this review 
were that the articles had to be in the English 
                                                          
†
 (((abstraction[Title/Abstract]) OR ("chart review" 
[Title/Abstract])) OR ("medical record review"[Title/Abstract])) 
AND ("clinical trial"[Title/Abstract] OR registry[Title/Abstract] 
OR "clinical research"[Title/Abstract] OR quality[Title/Abstract] 
OR "performance"[Title/Abstract]) AND (error[Title/Abstract] OR 
accuracy[Title/Abstract] OR "data quality"[Title/Abstract] OR 
errors[Title/Abstract] OR decision[Title/Abstract] OR 
reliability[Title/Abstract] OR validity[Title/Abstract]) 
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language, describe use of healthcare data with the 
medical record as the source, and mention at least 
one factor in the accuracy of medical record 
abstraction. 
Each reviewer independently read each included 
article and identified all statements of things that 
impact (increase, decrease, or stated without valence) 
accuracy of data abstracted from medical records. 
Each reviewer was instructed to combine 
semantically similar factors as such, e.g., 
reabstraction and independent re-review of charts 
were counted as one factor rather than two distinct 
factors. Factors stated at different levels of 
granularity or with different modifiers or context, 
e.g., reabstraction versus ongoing reabstraction were 
retained as separate factors.  Factors stated with 
opposing valence were retained as distinct factors, 
e.g., training abstractors increases accuracy versus 
lack of training decreases accuracy. Independent 
factor lists generated by each reader were compared 
and disagreements were resolved through discussion. 
This initial review identified 309 unique factors from 
1063 instances of mentioned factors in the literature. 
The list of distinct factors was used to categorize the 
Delphi Round 1 results. 
The factors were sorted by frequency of mention. 
Seventy five (24%) of the literature factors had 
greater than three mentions. These factors were 
combined with the factors obtained from Round 1 of 
the Delphi and were provided together to the 
participants in Round 2.  Factors from the literature 
were injected into the Delphi process at Round 2 
rather than Round 1 to prevent bias, e.g., participants 
agreeing with stated factors rather than providing 
factors most important from their experience.  In 
addition to standardized definitions, literature factors 
were introduced to reduce variability that could arise 
from different individual mental models of 
abstraction, e.g., some individuals consider case 
ascertainment as part of abstraction while others do 
not. The number of factors from the literature used in 
Round 2 was limited by the time allotted for the 
rounds, because the informed consent stated that each 
Round would take less than an hour. 
Member checking occurred as part of the Delphi 
design, i.e., participants see the aggregate results of 
the previous Delphi round. A peer debriefing session 
was conducted with 30 independent study 
coordinators from Duke University Medical Center 
in February 2010. 
Round 1 Results 
Round 1 of the Delphi returned 227 instances of 
mentioned factors from which 94 distinct factors 
receiving one or more mention were identified. 
Twenty seven (29%) of the distinct factors received 
greater than two mentions.  Six mentioned items fell 
outside of the working definition of Medical Record 
Abstraction. Five mentioned items could not be 
classified or otherwise labeled due to ambiguity of 
the information provided by the participant. Nine 
factors identified in Round 1 were not mentioned in 
the literature at all (Table 2).  Five factors were 
mentioned in the literature, but were not in the top 
24% (Table 3). 
Factor Number of 
Mentions 
Abstractor credentials 10 
Access to charts 6 
Interruptions 6 
Complete and accurate medical record 4 
Availability of abstraction tools 4 
Adequate time for abstraction tasks 4 
Complexity of the study or project 3 
Supportive collegial relationships 
with physicians, nurses, and 
medical records colleagues 
3 
Abstractor (human) error 3 
Table 2. Factors identified in Delphi Round 1 that 
were Not Found in the Literature 
 
Factor Number of 
Mentions 
Delphi / Literature 
Limited time 5 / 1 
Lack of training 4 / 2 
Same information found in 
multiple places in the medical 
record (opportunity for 
conflicting information) 
 
3 / 3 
Incomplete review of the 
medical record 
3 / 1 
Volume of information in the 
medical record 
3 / 1 
Table 3. Factors identified in Delphi Round 1 Not in 
the Literature top 24 % 
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A total of 89 distinct factors (the top 29% of the 
Round 1 responses and the top 24% of the literature 
factors) were carried forward to Round 2. The top 
29% and 24% correspond to > 2 and > 3 mentions 
respectively. Including all mentions in each category, 
i.e., all factors with >2 (Round 1) or >3 (literature) 
mentions, caused the difference in percentages.  
Three semantically redundant items were added to 
test internal consistency, seven items were created 
from existing factors containing multiple concepts;  
99 items were used in Round 2 of the Delphis.  
Round 1 Discussion 
Five of the factors not mentioned in the literature 
were combinable with higher level factors or were 
related to factors mentioned in the literature. For 
example, abstractor credentials received 10 mentions 
in the Delphi, while the literature contained mentions 
for “necessity of a RN”, “presence of an advanced 
degree”, and “certification of abstractors”14-17. For 
this analysis factors at different levels of granularity 
were not combined. 
“Adequate time for abstraction tasks” mentioned in 
the Delphi round 1, and “limited time” mentioned in 
both the Delphi round 1 and the literature were not 
combined. Likewise, “limited time” was not 
combined with “lack of resources”. “Access to 
charts” (Delphi Round 1), although related to 
“missing charts” (Literature) was not combined due 
to incomplete concept overlap and opposite valence. 
Similarly, “complete and accurate medical record” 
(Delphi Round 1) was not combined with “existing 
error in the medical record” (Literature). 
“Availability of abstraction tools” (Delphi Round 1) 
was not combined with any of the numerous more 
granular literature factors that mentioned different 
types of abstraction tools, e.g., data collection form, 
coding conventions, or data element definitions. The 
afore mentioned five factors, while exhibiting 
differences with factors reported in the literature are 
not considered by the authors as new factors 
identified through the Delphi. 
While the literature mentioned several instances of 
errors that the authors would classify as human error, 
e.g., “abstractor overlooked values in the medical 
record”, these instances were not classified to the 
universal human error by the authors. Human error 
and other factors considered by the authors as newly 
identified by the Delphi are bolded in Table 2. 
Delphi Results (all rounds) 
Combining both Delphis, there were 73 factors with 
overall average ratings between mildly and strongly 
agree, 75 registry & quality improvement, 71 clinical 
research. There were 3 factors with an overall rating 
lower than neutral, all of these were between mildly 
disagree and neutral. The registry and quality 
improvement Delphi rated 7 factors lower than 
neutral (Table 4).  The clinical research Delphi rated 
2 factors lower than neutral.  All factors rated lower 
than neutral originated from the literature. 
Factor CR R / QI Overall 
RN credential 3.2 2.2 2.8 
Blinding abstractors to 
study aims 
2.5 1.9 2.2 
Centralized 
abstraction 
3.2 2.7 3.0 
High study / project 
complexity 
3.8 2.5 3.3 
Thick medical records 3.2 2.8 3.1 
Patients cared for by 
multiple providers  
3.6 2.8 3.4 
Presence of multiple 
diagnoses / procedures 
2.8 2.6 2.7 
Table 4. Factors Rated Lower Than Neutral  
Discussion of Delphi Results (all rounds) 
The two strongly refuted factors, “necessity of the 
Registered Nurse credential”, and “blinding of 
abstractors” were contentious in the literature. Some 
argued for necessity of the RN credential due to the 
associated knowledge of data flow and 
documentation in the healthcare environment, ability 
to locate information in the medical record, and 
fluency in medical language6, 14-17. Others argued that 
individuals with clinical knowledge were more apt to 
interpret information in the medical record rather 
than rigidly follow abstraction guidelines. Having the 
RN credential strongly correlated with the perceived 
necessity of the credential for MRA. 
The literature was similarly conflicted regarding 
blinding of abstractors. Some argued that blinding 
abstractors to study endpoints prevented bias16, 18, 19. 
Others argued that knowledge of the study purpose 
and endpoints was necessary for abstractors to do a 
good job7, 17, 20. This difference in opinion may be 
due to different perceptions between investigators 
versus abstractors, or different application areas, e.g., 
explicit versus implicit abstraction. 
The low rating for presence of multiple diagnoses or 
procedures is puzzling.  This factor is cited by over 8 
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articles in the clinical research, registry and quality 
improvement literature as a factor impacting the 
accuracy of abstracted data. The reported mechanism 
is the difficulty assigning a primary diagnosis from 
multiple possible problems. Further, two large and 
robust studies in abstraction for billing conducted in 
1977 by the IOM reported this as a major finding21, 
22. It is possible that this is no longer a factor, or that 
while it may be a significant factor in claims 
abstracting, it is not problematic in other areas. 
Limitations 
Homogeneity of participants is a critical factor in the 
Delphi process. Our Delphi participants were 
homogenous with respect to abstraction setting 
(clinical research versus registry and quality 
improvement) and experience level. However, there 
is significant variation of practice within each setting. 
Further, factors that may impact medical record 
abstraction may vary across clinical area.  Thus, these 
results should be assessed in a particular practice area 
rather than blindly applied. Additionally, over 200 
factors mentioned in the literature, i.e., the bottom 
76%, could not be evaluated in this research.  
Conclusion 
From the consistency between the two Delphis, we 
conclude that the factors impacting accuracy are 
similar, i.e., differences between abstraction setting is 
not itself among the largest of factors, and that best 
practices and methods that improve accuracy in 
abstraction for registries and quality improvement 
projects may be applicable to clinical research.  
From the number of factors and the high level (73%) 
of agreement between expert abstractors and the 
literature, we conclude that data accuracy in MRA is 
a complex, many-faceted problem.  Thus, solutions to 
improving, controlling and assuring accuracy of 
abstracted data will necessarily be multi-faceted.  
The project received support from grant numbers 
UL1RR024128 and UL1RR024148 to Duke Univ. 
and Univ. of Texas Health Science Center Houston. 
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Abstract 
Medical record abstraction, a primary mode of data 
collection in secondary data use, is associated with 
high error rates. Distributed cognition in medical 
record abstraction has not been studied as a possible 
explanation for abstraction errors. We employed the 
theory of distributed representation and 
representational analysis to systematically evaluate 
cognitive demands in medical record abstraction and 
the extent of external cognitive support employed in a 
sample of clinical research data collection forms.     
We show that the cognitive load required for 
abstraction in 61% of the sampled data elements was 
high, exceedingly so in 9%. Further, the data 
collection forms did not support external cognition 
for the most complex data elements. High working 
memory demands are a possible explanation for the 
association of data errors with data elements 
requiring abstractor interpretation, comparison, 
mapping or calculation. The representational 
analysis used here can be used to identify data 
elements with high cognitive demands. 
Introduction 
Data collection in clinical research, both 
retrospective and prospective, relies on the 
abstraction of data from medical records1, 2. 
Abstraction is a time and resource intensive task3, 4 and 
is associated with high error rates5. However, little is 
known about the causes and mitigators of these 
errors6. Over time, authors have suggested that the 
design of the data collection form is a significant 
factor in the accuracy of abstracted data7, 8, 9, 10. 
Although data collection forms are widely touted as a 
key factor in data quality, little evaluative work has 
been done to understand the mechanism and impact 
of data collection form design on data accuracy. 
Today, the design of data collection forms is guided 
by primarily a-theoretical lists of things that form 
designers should and should not do8, 15, 16. 
While the role of paper-based patient records in 
clinician cognition has been studied14, the extent to 
which data collection forms impact cognition in 
clinical research data collection has not yet been 
investigated. Furthermore, cognitive science models 
and methodology have yet to be applied to medical 
record abstraction in clinical research or other 
secondary data use settings. 
From cognitive science we know that distribution of 
information across internal and external 
representations, i.e., in the user’s mind and in the 
world, affects human task performance13. 
Additionally, representation can extend human 
performance through external cognition12, 13. Thus, 
data collection forms may impact data accuracy 
through form representation that supports distributed, 
i.e., external cognition, and through the number and 
extent of mental steps between the data source and 
the collection form.   
We applied the distributed cognition framework12 and 
adapted Gong’s information search model11 to 
medical record abstraction, and applied them through 
a representational analysis to perform a systematic 
evaluation of paper data collection forms to 1) 
identify the type and extent of internal cognition 
required in medical record abstraction, and 2) to 
characterize the extent of support for external 
cognition in data collection forms.   
Background 
Medical record abstraction entails the identification 
of required data in the medical record, 
transformations of that data, and recording the data 
onto data collection forms. While two 
representations, 1) the source medical record, and 2) 
the destination data collection form, may impact data 
accuracy, secondary data users usually cannot impact 
how data are represented in the medical record.  
However, secondary users can control the 
representation of their data collection forms, e.g., 
data collection forms often employ form instructions, 
prompts, and structural or graphical elements to 
guide form completion8, 15, 16. However, the presence 
of these elements, their extent and format are 
inconsistent on data collection forms 15. Since data 
collection forms are present during the abstraction, 
and within control of the secondary data users, there 
is reason to believe that they may provide a 
mechanism to decrease cognitive load by increasing 
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support for external cognition during the abstraction 
process. 
In his 2006 work, Gong applied the theory of 
distributed representation to explore how information 
distribution between internal and external 
representations affects information search 
performance11. He demonstrated that search task 
performance improved with increasing amounts of 
information represented externally11. Further, this and 
other work, has shown that search task performance 
improves when the scales17 between the task and the 
data representation match11, 12.  
Because medical record abstraction is both a search 
and a cognitively intense process, the Gong model 
has particular utility for exploring and characterizing 
the extent to which data collection forms support 
distributed cognition in medical record abstraction. 
As such, we adapted Gong’s model to the task of 
medical abstraction (Figure 1).  Document boxes 
were added for medical record and data collection 
form representation. Task boxes were added for both 
documentation and abstraction tasks. Remember, 
transform, and transcribe are shown at the sub-task 
level, clearly delineating them from the search sub-
task. In addition, localize from Gong’s model was 
considered a direct search sub-task, while compare 
and calculate were relocated to the transform sub-
task along with additional transformations interpret, 
map, and scale conversion, i.e., a transformation 
from one scale to another, e.g., ratio representation in 
the medical record, and data collection form 
representation as an ordinal category. Importantly, all 
tasks presented opportunities for distributed 
cognition. Light grey boxes were added for 
completeness but are not evaluated here. 
In medical record abstraction, information is 
represented both in the medical record and on the 
data collection form.  Therefore, there are 
opportunities for mismatch between 1) the 
represented information and the representing medical 
record, 2) the representing medical record and the 
representing data collection form 3) the represented 
information and the representing data collection 
form. Moreover, the search, remember, transform, 
and transcribe tasks are performed internally and 
likely increase working memory load unless external 
cognition artifacts exist.  
While the medical record may have artifacts that 
enable external cognition for search tasks, the 
remember, transform, and transcribe tasks are unique 
to each secondary data use.  Therefore, we expect 
that medical record representation will not provide 
significant opportunities for external cognitive 
support for these tasks.  Thus, we evaluated paper 
data collection form external cognition artifacts 
rather than any particular medical record 
representation.  
In medical record abstraction, virtually every data 
element by definition has a search task. Each data 
element may or may not have form artifacts 
supporting external cognition. Further, for each data 
element, zero to multiple transform tasks may apply. 
Each transform task required for a data element may 
or may not have an external cognition artifact. 
 
Figure 1. Model of Cognition in Medical Record Abstraction 
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Methods 
Fifteen structured paper-based data collection form 
modules* were randomly selected from the data 
collection form library at the Duke Clinical Research 
Institute. The library houses data collection forms, 
many of which have been broken out by modules.  
We sampled the 256 available modules, randomly 
selecting 15 modules.  Once nine unique trials were 
obtained, the remaining five modules were accepted 
sequentially only if they were from a trial already 
selected for the sample. This allowed comparison 
between forms within a trial.  
The fifteen modules were from nine different clinical 
trials completed from 1992-2004. The module types 
and number of data elements per module are listed in 
Table 1. In total, 250 data elements were assessed. 
Module Type Data 
Elements*  
Patient status (Trial 1) 25  
Drug administration (Trial 1) 9 
Canadian Cardiovascular Society Class (Trial  2) 4 
Pacemaker mode change form (Trial 2) 32 
Drug administration (Trial 3) 18 
Platelet count (Trial 3) 12 
Post procedure repeat catheterization (Trial 4) 18 
Cardiac markers (Trial 5) 26 
Clinical global impression (Trial 6) 6 
Thyroid function tests (Trial 6) 12 
Serum pregnancy test (Trial 6) 6 
Medical history (Trial 7) 14 
30 Day follow-up (Trial 8) 48 
30 Day follow-up (Trial 9) 11 
Cardiac enzymes (Trial 9) 9 
* Only unique data elements were assessed and counted 
Table 1. Characterization of Modules Selected for 
this Study. 
Ten of the analyzed modules reflected different data 
content areas. Five of the analyzed modules were 
different representations (isomorphs) of the same 
content, e.g., lab results, from different forms 
collected in different formats. The analysis of 
multiple instances of similar module content allowed 
assessment of differences in representation of similar 
data elements. 
For the representational analysis, each data element 
was reviewed and classified by two independent 
reviewers (informatics graduate students in a health 
data display class) who were both novices to medical 
                                                          
*
 A module is a section of a data collection form containing data 
grouped by topicality, e.g., vital signs, physical exam, lab results. 
Modules are usually, but not always less than a page. 
record abstraction. Our unit of analysis was the data 
element, i.e., a form question and the associated 
response field† Each reviewer classified the 
following eight aspects of each data element: Scale of 
the represented information (nominal, ordinal, 
interval, ratio), Data collection form representing 
scale, Scale of the abstraction task, Presence of a 
search task (yes, no), Presence of external 
representation for the search task (yes, no), Type of 
other transform tasks, if present (compare, calculate, 
interpret, other), Enumeration of dimensions required 
to abstract the data element, and whether the Rule 
representation for the abstraction task and 
transformations was (internal, external). 
Briefly, a search task is the locating of a data value, 
e.g., finding documentation of the gender of a subject 
in the medical record. A transform task is a 
manipulation or conversion of a data value, e.g., 
categorizing a specific medication according to class, 
or converting units on a lab value or drug dose. The 
rule is the logic that defines such a transformation. 
For this analysis, scale conversions were counted 
separately from other transformations. 
A third person experienced in medical record 
abstraction adjudicated the work of the two 
independent reviewers; discrepancies were resolved 
by the adjudicator and final data were reviewed by all 
three reviewers. 
We recognize that the representation in the medical 
record likely impacts cognition during medical record 
abstraction. However, we did not assess 
representation in the medical record because 1) 
medical record systems should optimize cognitive 
support for care delivery and clinical documentation 
rather than secondary data use, and 2) medical record 
representation differs from institution to institution. 
The impact of medical record representation on 
accuracy of abstracted data remains an area for future 
research. Similarly, abstractor experience may also 
impact cognitive demands by obviating of the need 
for transform through direct association, e.g., body 
mass index of 47 equating to obese.  Impact of 
abstractor experience remains an area for future 
research. 
Results 
Of the 250 data elements assessed, 98 (39%) were 
direct transcription, i.e., once the value was located 
in the medical record, it could be copied directly onto 
the data collection form without transformation. For 
example, a blood pressure value recorded in the 
                                                          
†
 Data element is formally defined in ISO/IEC 11179-1. 
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medical record in the same units as those required on 
the data collection form did not need interpretation or 
calculation if collected as a numeric value.  
The majority of the data elements, 152 (61%) 
required transformation of some type. Cognitively, 
transformation means that a rule is required to 
change the data value from its source state to the 
destination state on the data collection form. 
Collection of age on the data collection form is an 
example; age would need to be calculated from the 
date of birth and the date of the screening visit.  The 
types of transformation required include comparison, 
calculation, interpretation and mapping, shown by 
percentage in Table 2. Scale transformations were 
counted separately. In addition, 37 (15%) of the data 
elements required more than one transformation.  
Transformation Type Percent 
Comparison 43% 
Mapping (categorization) 29% 
Interpretation (also included synthesis) 14% 
Calculation 14% 
Table 2. Characterization of Transformation 
The data collection form representation for each data 
element was assessed and categorized as either 
supporting external cognition or not.  As expected, 
external cognition for the 98 direct transcription data 
elements was supported by the data collection form. 
For these data elements, the form prompt and field 
structure made the search and transcription tasks 
perceptually evident, i.e., no additional cognition on 
the part of the human abstractor required.  
Supporting external cognition for the transformation 
(rule based) tasks, is more difficult. Unfortunately, 
the cognitively more complex data elements, i.e., the 
152 data elements requiring transformations, were 
not supported by form-based external cognition 
artifacts.  One hundred and thirteen (74%) of these 
complex data elements, required internal cognition. 
The number of dimensions, i.e., individual distinct 
pieces of information, for example, using two 
dimensions, today’s date and birth date to calculate 
today’s age, required for each transformation was 
also assessed.  The mean number of dimensions 
required for abstracting the data elements that needed 
a transformation was 2.6, with a range of 1 to 45 
dimensions required. For example, an abstractor must 
compare, map, interpret, or calculate 45 distinct 
pieces of information. The highest number, 45 was a 
data element asking for enumeration of inclusion and 
exclusion criterion that were not met requiring 
internal assessment of each. Unless external 
cognitive support is provided, e.g., a worksheet, or 
created by the abstractor, e.g., a scratch pad, the 
values for each dimension are held in the abstractor’s 
head prior to and during the transformation.  
Therefore, the dimension counts indicate the 
cognitive load required for the transformation. 
Scale mismatch between the represented information, 
the abstraction task, and the data collection form 
representation further impacted internal cognitive 
demands on the abstractor by requiring mental 
transformations from one scale to another. Each data 
element was categorized three ways according to 
Steven’s17 nominal, ordinal, interval, and ratio scales, 
1) the scale of the represented information, 2) the 
scale of the abstraction task, i.e., the transformation 
or transcription, and 3) the scale of the data 
collection form representation.  Table 3 shows the 
overall shift in scale from the represented 
information to the data collection form 
representation. 
 Data Collection Form Representation 
Represented Nominal Ordinal Interval Ratio 
Nominal (138) 138 0 0 0 
Ordinal (19) 16 3 0 0 
Interval (29) 1 0 28 0 
Ratio (64) 23 3 0 38 
 178 6 28 38 
Table 3. Scale “down shift” from Represented 
Information to Data Collection Form 
Overall, 43 (17%) of the data elements were reduced 
from the represented information scale to the data 
collection form representation. This down shift 
requires transformation, usually in the form of 
mapping, interpretation, or categorization. Thus, 
scale mismatch adds to the already significant 
cognitive load on the human abstractor.   
Discussion 
Although from only a limited evaluation in a small 
sample of paper data collection forms, the results 
reported here document the significant cognitive 
demands in medical record abstraction. A human can 
hold on average from 5-7 chunks of information in 
working memory18. Our results show that on average, 
the cognitive demands for many CRF data elements 
bump up against the limits of human cognition. 
Further, the 9% of data elements requiring four or 
more dimensions, when added to cognitive load from 
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transformations, can easily exceed working memory 
limits. Moreover, the paper data collection forms 
analyzed had few, if any, external cognition artifacts 
to support the most cognitively demanding data 
elements. 
Other authors have cited requiring “abstractor 
judgment” or “interpretation” as a cause of errors in 
medical record abstraction6, 8, 9, 10. However, none have 
suggested why these errors occur or the nature of 
their relationship to other types of data error in 
medical record abstraction.  Likewise, the literature 
does not suggest concrete methods of mitigating or 
preventing the resulting data errors. Our results 
contribute a possible explanation and mechanism for 
a portion of the data accuracy problem in medical 
record abstraction.  In addition, the theory of 
distributed representation and the associated 
representational analysis used here can be applied to 
analyze data element representation on data 
collection forms and abstraction tasks to prevent or 
lessen the likelihood of cognitive limit related 
abstraction errors. The representational analysis used 
here can be performed during form design to identify 
high cognitive load data elements and to evaluate 
isomorphs. Such an application would improve form 
design by identifying high cognitive load data 
elements so that they can be replaced with lower 
cognitive load isomorphs. Further, both electronic 
medical records and electronic data collection forms, 
provide additional opportunities for decreasing 
cognitive load. Confirming these results in a larger 
and more diverse sample of forms and medical 
records, and evaluation of data accuracy from data 
collection form isomorphs are key next steps in this 
area of inquiry. 
Conclusion 
The cognitive load required for abstraction of 61% of 
the data elements in our sample was both high and 
unsupported with external cognition artifacts on the 
data collection forms, exceedingly so for 9% of the 
data elements. The high working memory demands 
are a possible explanation for the association of data 
errors in medical record abstraction with data 
elements that require abstractor interpretation, 
comparison, mapping or calculation. Existing 
methods of representational analysis can be applied 
to identify data elements with high cognitive 
demands and help form designers identify and avoid 
them in form design.  Further, representational 
analysis provides a tool to analyze form isomorphs 
and identify those with the lowest cognitive 
demands. 
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